Hutch News
Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
May 24, 2023
Learning to trust science with your life
Diseases like cancer and COVID-19 can be scary; leaning into the science helps you feel more empowered
New study highlights lack of diversity and inclusion in vaccine clinical trials
Analysis shows certain racial/ethnic groups and older people aren’t being adequately represented and trial reporting guidelines aren’t being followed
Building trust in safe and effective COVID-19 vaccines
Convincing millions to get vaccinated will take more than data, facts and figures
Vaccines stop COVID-19 symptoms, but do they stop transmission?
Researchers mull options, including college dorm studies and 'human challenge' trials, to find answer
Public health’s pandemic pivot
With disease modeling, virtual events and a renewed focus on antiracism, Fred Hutch population scientists adapt their work to COVID-19
Obliteride brings in $2M to spur cancer, COVID-19 research
Annual Fred Hutch fundraiser goes virtual and DIY; sets records for participation, creativity and global reach
New HIV vaccine trial to launch in U.S., Latin America and Europe
‘Mosaico’ will enroll 3,800 transgender people and men who have sex with men
First licensed dengue vaccine withstands rainy season
From the Vaccine and Infectious Disease Division
Ebola lessons applied to vaccine clinical trials
3 proposals for ‘thinking outside the box’ in public health emergencies
New breast cancer vaccine ‘promising but not ready for prime time’
Vaccine potentially could be used in the majority of breast cancer patients
Finding a better way to take a bite out of malaria’s power
Fred Hutch and collaborators launch new trials to infect – and quickly treat – volunteers to test experimental drugs
Fred Hutchinson Cancer Research Center and Seattle BioMed team up on malaria clinical trials
Studies to test drugs that may be useful for malaria treatment and prevention
New vaccine may prevent cytomegalovirus infection
Vaccine and Infectious Disease Institute researchers co-author study on vaccine with potential to prevent the most common virus transmitted by a pregnant woman to her unborn child